Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.49 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | EED | O75530 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TTBK1 | Q5TCY1 | 1/20 | 0.35 |
| ▸ | TTBK2 | Q6IQ55 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.33 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.33 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL161792 | 0.81 | GSK3B (0.54) | GSK3BABCG2MAOBKDM4EEED | |
| SCHEMBL29706697 | 0.81 | GSK3B (0.54) | GSK3BABCG2MAOBKDM4EEED | |
| SCHEMBL16398867 | 0.79 | GSK3B (0.49) | GSK3BABCG2MAOBKDM4EEED | |
| SCHEMBL4803778 | 0.79 | GSK3B (0.49) | GSK3BABCG2MAOBKDM4EEED | |
| SCHEMBL13972664 | 0.76 | MAOB (0.50) | GSK3BABCG2MAOBKDM4EEED | |
| SCHEMBL6061016 | 0.76 | — | — | |
| SCHEMBL7228549 | 0.75 | GSK3B (0.45) | GSK3BABCG2MAOBKDM4EEED | |
| SCHEMBL9670572 | 0.75 | GSK3B (0.45) | GSK3BABCG2MAOBKDM4EEED | |
| SCHEMBL9645979 | 0.75 | GSK3B (0.45) | GSK3BABCG2MAOBKDM4EEED | |
| SCHEMBL18936053 | 0.75 | KDM4E (0.33) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025047654-A1 | POSITIVE PHOTOSENSITIVE PIGMENT COMPOSITION, CURED FILM CONTAINING CURED PRODUCT THEREOF, ORGANIC EL DISPLAY DEVICE, ELECTRONIC APPARATUS, AND BLOCK COPOLYMER | 東レ株式会社 | 2025-03-06 | — | — | WO | disclosed |
| EP-3209639-B1 | COMPOUNDS AS ANTI-MALARIALS AND THEIR PROCESS OF PREPARATION | COUNCIL SCIENT IND RES (IN) | 2020-09-16 | — | — | EP | disclosed |
| US-20190106380-A1 | Aromatic Derivatives As Anti-Malarial | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2019-04-11 | — | — | US | disclosed |
| CN-109381462-A | A kind of hypoglycemic purposes of piperlongumine Alkaloid | 中国科学院新疆理化技术研究所 | 2019-02-26 | — | — | CN | disclosed |
| CN-109350614-A | A kind of hypoglycemic purposes of piperlongumine alkaloid | 中国科学院新疆理化技术研究所 | 2019-02-19 | — | — | CN | disclosed |
| EP-1551885-B1 | PROCESS TO MODIFY POLYMERIC MATERIALS | 3M INNOVATIVE PROPERTIES CO (US) | 2016-02-17 | — | — | EP | disclosed |
| US-8101711-B2 | Process to modify polymeric materials and resulting compositions | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-01-24 | — | — | US | disclosed |
| US-20100048819-A1 | PROCESS TO MODIFY POLYMERIC MATERIALS AND RESULTING COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY | 2010-02-25 | — | — | US | disclosed |
| US-7632916-B2 | Thermally induced graft polymerization in an apparatus by shearing, devolatilization; grafting isoprene-t-butyl methacrylate copolymer with polyoxyethylene glycol methyl ether, forming methacrylic acid/anhydride monomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-12-15 | — | — | US | disclosed |
| US-20070122915-A1 | Continuous process for the production of combinatorial libraries of modified materials | 3M INNOVATIVE PROPETIES COMPANY | 2007-05-31 | — | — | US | disclosed |
| US-20070078120-A1 | Novel piperidine derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| US-7157283-B2 | Continuous process for the production of combinatorial libraries of modified materials | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-01-02 | — | — | US | disclosed |
| EP-1551885-A2 | PROCESS TO MODIFY POLYMERIC MATERIALS AND RESULTING COMPOSITIONS | 3M Innovative Properties Company (US) | 2005-07-13 | — | — | EP | disclosed |
| EP-1551547-A1 | A CONTINUOUS PROCESS FOR THE PRODUCTION OF COMBINATORIAL LIBRARIES OF MODIFIED MATERIALS | 3M Innovative Properties Company (US) | 2005-07-13 | — | — | EP | disclosed |
| WO-2004012858-A1 | A CONTINUOUS PROCESS FOR THE PRODUCTION OF COMBINATORIAL LIBRARIES OF MODIFIED MATERIALS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-02-12 | — | — | WO | disclosed |
| WO-2004013189-A2 | PROCESS TO MODIFY POLYMERIC MATERIALS AND RESULTING COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-02-12 | — | — | WO | disclosed |
| US-20040023398-A1 | Continuous process for the production of combinatorial libraries of modified materials | 3M INNOVATIVE PROPERTIES COMPANY | 2004-02-05 | — | — | US | disclosed |
| US-20040024130-A1 | Process to modify polymeric materials and resulting compositions | 3M INNOVATIVE PROPERTIES COMPANY | 2004-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190106380-A1 | Aromatic Derivatives As Anti-Malarial | TYR, CYP3A43, H1-3 | GSK3B 2488/4885ABCG2 4/4885MAOB 198/4885 |
| US-20070078120-A1 | Novel piperidine derivative | LDLR, PRMT5, MSR1 | GSK3B 4076/4885ABCG2 829/4885MAOB 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.